The future of coeliac disease: immunology, environment and possibilities for new treatments.
- Conditions
- Coeliac sprueGluten intolerance1002547710003816
- Registration Number
- NL-OMON44841
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 400
All children that undergo diagnostic upper gastrointestinal endoscopy under general anesthesia for medical reasons in the Willem-Alexander Children*s Hospital of the LUMC are eligible for the study. Around 120 children undergo upper gastrointestinal endoscopy in the Department of Pediatrics of the LUMC each year. They will be divided in
- Cases: all children that are diagnosed with coeliac disease according to accepted criteria
- Controls: all children that are diagnosed with other conditions unrelated to coeliac disease ;Informed consent and suffiecient knowledge / understanding of the Dutch language are mandatory
- No informed consent
- Insufficient knowledge / understanding of Dutch language
- Prior participation in protocol P06.140 or the present study if subject has undergone more than one endoscopy.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Definition of the disease associated T cell receptor repertoire in a large<br /><br>group of paediatric patients.<br /><br>Determination of the functional characteristics of the disease associated T<br /><br>cells.<br /><br>Correlation of the disease associated T cell receptor repertoire with disease<br /><br>onset and/or severity<br /><br>Phenotypic and functional characterisation of the intraepithelial lymphocyte<br /><br>compartment in patients with and without CD.<br /><br>Analysis of the cytokine mediated crosstalk between the lamina propria and<br /><br>epithelial compartments.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Ultimately we aim to develop novel diagnostics and preventive and therapeutic<br /><br>approaches for CD.</p><br>